M-CSF, combined with IL-34, tumor associated macrophages (TAMs) were the novel biological markers for GC, which may provide new insight for both the diagnosis and cellular therapy of GC (Liu et al., 2020). This evidence concerns the gene CSF1 and neoplasm.